Markets

DENTSPLY SIRONA Inc. (XRAY): More In-Depth Monitoring is Needed

DENTSPLY SIRONA Inc. (NASDAQ:XRAY) is an interesting stock at present. Now trading with a market value of 13.41B, the company has a mix of catalysts and obstacles that spring from the nature of its operations. As the day-to-day narrative ebbs and flows for this company, it is more important than ever to step back and get a bird’s eye view of the fundamental reality under the surface of this story.

DENTSPLY SIRONA Inc. (NASDAQ:XRAY) Fundamentals That Matter

It’s generally a good idea to start with the most fundamental piece of the picture: the balance sheet. The balance sheet health of any company plays a key role in its ability to meet its obligations and maintain the faith of its investment base. For XRAY, the company currently has 370 million of cash on the books, which is offset by 21.4 million in current liabilities. The trend over time is important to note. In this case, the company’s debt has been falling. The company also has 11.2 billion in total assets, balanced by 3.71 billion in total liabilities, which should give you a sense of the viability of the company under any number of imagined business contexts.

DENTSPLY SIRONA Inc. (XRAY) saw 130.5 million in free cash flow last quarter, representing a quarterly net change in cash of 101.6 million. Perhaps most importantly where cash movements are concerned, the company saw about 164.3 million in net operating cash flow.



DENTSPLY SIRONA Inc. (NASDAQ:XRAY) Revenue Growth Potential

As far as key trends that demonstrate something of the future investment potential of this stock, we need to take a closer look at the top line, first and foremost. Last quarter, the company saw 1.01 billion in total revenues. That represents a quarterly year/year change in revenues of 0.06 in sequential terms, the XRAY saw sales decline by 0.02.

But what about the bottom line? After all, that’s what really matters in the end. DENTSPLY SIRONA Inc. (XRAY) is intriguing when broken down to its core data. The cost of selling goods last quarter was 448.6 million, yielding a gross basic income of 560.6 million. For shareholders, given the total diluted outstanding shares of 233.1 million, this means overall earnings per share of 0.39. Note, this compares with a consensus analyst forecast of 0.48 in earnings per share for its next fiscal quarterly report.




Is DENTSPLY SIRONA Inc. (NASDAQ:XRAY) Valuation Attractive

Looking ahead at valuations, according to the consensus, the next fiscal year is forecast to bring about 3.07 in total earnings per share. If we consider a median price to earnings ratio on the stock, that corresponds with a stock price of 20.23. However, one should always remember: the trends are more important than the forecasts. This continues to be an interesting story, and we look forward to updating it again soon on DENTSPLY SIRONA Inc..

Previous ArticleNext Article

Related Post

How Does the Fundamental Picture Look for Pfizer I... Pfizer Inc. (NYSE:PFE) trade is getting exciting but lets take a deeper look whether it is as good a moment. Now trading with a market value of 200.46...
Rand Logistics, Inc. (RLOG) Raising Eyebrows Among... Rand Logistics, Inc. (NASDAQ:RLOG) is one of the active stocks and its unusual movement is raising eyebrows among traders. Now trading with a market v...
Zynga Inc. (ZNGA) Forming A Pattern Of Major Movem... It is interesting to note that Zynga Inc. (NASDAQ:ZNGA) is active and made a solid movement in the last trading day. Now trading with a market value o...
It’s worth it to have a look at Morgan Stanl... Morgan Stanley (NYSE:MS)'s interesting series of developments are underway around the US stock market these days. Now trading with a market value of 9...
The New York Times Company (NYT): Checking the Ope... The New York Times Company (NYSE:NYT) has recently been identified as an interesting stock but more in-depth monitoring is needed for a trade decision...